FDA Shoots Down Needle-Free EpiPen Alternative, Requests More Data

(MedPage Today) -- The FDA declined to approve an epinephrine nasal spray (ARS-1, also known as neffy), requesting that an additional premarketing study be conducted, maker ARS Pharmaceuticals announced. The company is seeking an indication for...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news